Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10449822.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Portal vein resection during pancreaticoduodenectomy has recently experienced renewed interest. We describe our results with this procedure over a 20-year period. Among 88 consecutive pancreatectomies for cancer of head of the pancreas, 14 included en bloc removal of the portal vein. There was no hospital mortality. Only 21% were found to have histologically confirmed cancer invasion, and the remainder had inflammatory adherence. Two-year survival was 15% compared to 34% for patients who did not have portal vein resection. There were no 5-year survivors. We discuss our results in light of other recent reports.
Medical subject headings
- Adenocarcinoma
- Pancreatic Neoplasms
- Pancreaticoduodenectomy
- Portal Vein